ACTIVE SUBSTANCE / INN

MORPHINE SULFATE

Brand name(s): ARYMO ER, KADIAN, DURAMORPH PF, ASTRAMORPH PF, ORAMORPH SR, MORPHINE SULFATE, DEPODUR, MS CONTIN, INFUMORPH
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA018565
NDA021671
ACTIVE SUBSTANCE
Morphine Sulfate
REGULATORS
FDA
SPONSORS / MAH
ZYLA, CHARTWELL MOLECULAR, PACIRA PHARMS INC
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MORPHINE SULFATEANDA078761SUN PHARM INDS LTDPrescription
MORPHINE SULFATEANDA202309CHARTWELL MOLECULARDiscontinued
KADIANNDA020616ALLERGANDiscontinued
DEPODURNDA021671PACIRA PHARMS INCDiscontinued
MS CONTINNDA019516PURDUE PHARMA LPPrescription
ARYMO ERNDA208603ZYLADiscontinued
ASTRAMORPH PFANDA071051FRESENIUS KABI USADiscontinued
ORAMORPH SRNDA019977XANODYNE PHARMS INCDiscontinued
DURAMORPH PFNDA018565HIKMAPrescription
INFUMORPHNDA018565HIKMAPrescription

FULL INTELLIGENCE ON MORPHINE SULFATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →